Vidya Perera possesses extensive experience in clinical development and pharmacology, currently serving as VP and Global Head of Early Clinical Development for CV, Renal, Acute Care, and Immunology at Bayer since June 2023. Previously, Vidya held multiple leadership positions at Bristol Myers Squibb from November 2016 to June 2023, including Early Development Program Lead and Senior Director for Clinical Pharmacology and Pharmacometrics. Additional experience includes roles as Affiliate Research Scientist at Schizophrenia Research Institute and Adjunct Assistant Professor at University at Buffalo, alongside a senior managerial position at Noven Pharmaceuticals.
This person is not in the org chart
This person is not in any teams
This person is not in any offices